Esomeprazole and omeprazole could possibly enhance the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to increased adverse effects such as drowsiness, Even though the clinical relevance is small in the majority of patients – monitor the client for adverse effects (e.If patient can not resume their common oral medication